Table 1 Open in new tab Baseline Patient...

		N	Prop (%)	N	Prop (%)	N	Prop (%)	N	Prop (%)	P χ²	Q1	Med	Q3	P KW
Time to Treatment Completion			40–46 days		47–53 days		54+ days			42	43	45
		13489		11464	85.0%	1531	11.3%	494	3.7%
Time to Treatment Initiation									< .001				< .001
	1-21 days	3044	22.6%	2471	81.2%	388	12.7%	185	6.1%		43	43	45
	22-42 days	8913	66.1%	7738	86.8%	924	10.4%	251	2.8%		42	43	44
	43+ days	1532	11.4%	1255	81.9%	219	14.3%	58	3.8%		43	43	45
Age										.439				.156
	(18-40)	731	5.4%	627	85.8%	76	10.4%	28	3.8%		42	43	45
	(40-50)	1671	12.4%	1422	85.1%	184	11.0%	65	3.9%		42	43	45
	(50-60)	3880	28.8%	3296	84.9%	440	11.3%	144	3.7%		42	43	45
	(60-70)	4471	33.1%	3830	85.7%	497	11.1%	144	3.2%		42	43	45
	(70-+)	2736	20.3%	2289	83.7%	334	12.2%	113	4.1%		43	43	45
Sex										.009				.012
	Male	8131	60.3%	6984	85.9%	876	10.8%	271	3.3%		42	43	45
	Female	5358	39.7%	4480	83.6%	655	12.2%	223	4.2%		43	43	45
Race										.001				.002
	White	X	92.1%	10596	85.3%	1383	11.1%	X	3.6%		42	43	45
	Black	X	4.9%	523	78.6%	105	15.8%	X	5.6%		43	43	45
	Asian	X	1.5%	187	89.5%	16	7.7%	X	2.9%		43	43	44
	Other	X	1.4%	158	81.9%	27	14.0%	X	4.1%		42	43	45
Hispanic Origin									.637				.068
	Non-Hispanic	12928	95.8%	10995	85.0%	1462	11.3%	471	3.6%		42	43	45
	Hispanic	561	4.2%	469	83.6%	69	12.3%	23	4.1%		43	43	45
Insurance Status									< .001				< .001
	Private Insurance	7580	56.2%	6540	86.3%	775	10.2%	265	3.5%		42	43	44
	Not Insured	477	3.5%	386	80.9%	73	15.3%	18	3.8%		43	44	45
	Government	5432	40.3%	4538	83.5%	683	12.6%	211	3.9%		43	43	45
Facility Type										.011				.004
	Academic	X	43.4%	X	85.4%	X	10.6%	X	3.9%		42	43	44
	Community	X	44.1%	X	84.5%	X	12.0%	X	3.5%		43	43	45
	Integrated	X	6.9%	X	84.8%	X	12.6%	X	2.6%		43	43	45
	Other	X	0.1%	X	60.0%	X	26.7%	X	13.3%		43	44	49
	Suppressed (age < 40)	X	5.4%	X	85.8%	X	10.4%	X	3.8%		42	43	45
Distance to Treatment Facility									.164				.002
	(0-50)	11811	87.6%	10035	85.0%	1344	11.4%	432	3.7%		42	43	45
	(50-100)	1063	7.9%	899	84.6%	131	12.3%	33	3.1%		43	43	45
	(100-+)	615	4.6%	530	86.2%	56	9.1%	29	4.7%		42	43	44
Charlson/Deyo Comorbidity Score									.303				.015
	0	10268	76.1%	8765	85.4%	1139	11.1%	364	3.5%		42	43	45
	1	2024	15.0%	1696	83.8%	247	12.2%	81	4.0%		43	43	45
	2+	1197	8.9%	1003	83.8%	145	12.1%	49	4.1%		43	43	45
Diagnosis Year									.003				< .001
	2005	1030	7.6%	856	83.1%	139	13.5%	35	3.4%		43	44	45
	2006	1230	9.1%	1023	83.2%	157	12.8%	50	4.1%		43	43	45
	2007	1405	10.4%	1178	83.8%	178	12.7%	49	3.5%		43	43	45
	2008	1561	11.6%	1304	83.5%	188	12.0%	69	4.4%		42	43	45
	2009	1685	12.5%	1425	84.6%	200	11.9%	60	3.6%		42	43	45
	2010	2041	15.1%	1728	84.7%	226	11.1%	87	4.3%		42	43	45
	2011	2215	16.4%	1930	87.1%	209	9.4%	76	3.4%		42	43	44
	2012	2322	17.2%	2020	87.0%	234	10.1%	68	2.9%		42	43	44
Zip Code Income Level									.003				.003
	($63K-+)	4840	35.9%	4180	86.4%	496	10.2%	164	3.4%		42	43	44
	($48K-63K)	3908	29.0%	3349	85.7%	416	10.6%	143	3.7%		42	43	45
	($38K-$48K)	2991	22.2%	2494	83.4%	380	12.7%	117	3.9%		42	43	45
	(0-$38K)	1750	13.0%	1441	82.3%	239	13.7%	70	4.0%		42	43	45

Prop (%)

P χ²

Med

P KW

Overall Cohort

TTI Groups

Time to Treatment Completion

40–46 days

47–53 days

54+ days

13489

11464

85.0%

1531

11.3%

494

3.7%

Time to Treatment Initiation

< .001

1-21 days

3044

22.6%

2471

81.2%

388

12.7%

185

6.1%

22-42 days

8913

66.1%

7738

86.8%

924

10.4%

251

2.8%

43+ days

1532

11.4%

1255

81.9%

219

14.3%

3.8%

Age

.439

.156

(18-40)

731

5.4%

627

85.8%

10.4%

3.8%

(40-50)

1671

12.4%

1422

85.1%

184

11.0%

3.9%

(50-60)

3880

28.8%

3296

84.9%

440

11.3%

144

3.7%

(60-70)

4471

33.1%

3830

85.7%

497

11.1%

144

3.2%

(70-+)

2736

20.3%

2289

83.7%

334

12.2%

113

4.1%

Sex

.009

.012

Male

8131

60.3%

6984

85.9%

876

10.8%

271

3.3%

Female

5358

39.7%

4480

83.6%

655

12.2%

223

4.2%

Race

.001

.002

White

92.1%

10596

85.3%

1383

11.1%

3.6%

Black

4.9%

523

78.6%

105

15.8%

5.6%

Asian

1.5%

187

89.5%

7.7%

2.9%

Other

1.4%

158

81.9%

14.0%

4.1%

Hispanic Origin

.637

.068

Non-Hispanic

12928

95.8%

10995

85.0%

1462

11.3%

471

3.6%

Hispanic

561

4.2%

469

83.6%

12.3%

4.1%

Insurance Status

< .001

Private Insurance

7580

56.2%

6540

86.3%

775

10.2%

265

3.5%

Not Insured

477

3.5%

386

80.9%

15.3%

3.8%

Government

5432

40.3%

4538

83.5%

683

12.6%

211

3.9%

Facility Type

.011

.004

Academic

43.4%

85.4%

10.6%

3.9%

Community

44.1%

84.5%

12.0%

3.5%

Integrated

6.9%

84.8%

12.6%

2.6%

Other

0.1%

60.0%

26.7%

13.3%

Suppressed (age < 40)

5.4%

85.8%

10.4%

3.8%

Distance to Treatment Facility

.164

.002

(0-50)

11811

87.6%

10035

85.0%

1344

11.4%

432

3.7%

(50-100)

1063

7.9%

899

84.6%

131

12.3%

3.1%

(100-+)

615

4.6%

530

86.2%

9.1%

4.7%

Charlson/Deyo Comorbidity Score

.303

.015

10268

76.1%

8765

85.4%

1139

11.1%

364

3.5%

2024

15.0%

1696

83.8%

247

12.2%

4.0%

1197

8.9%

1003

83.8%

145

12.1%

4.1%

Diagnosis Year

.003

< .001

2005

1030

7.6%

856

83.1%

139

13.5%

3.4%

2006

1230

9.1%

1023

83.2%

157

12.8%

4.1%

2007

1405

10.4%

1178

83.8%

178

12.7%

3.5%

2008

1561

11.6%

1304

83.5%

188

12.0%

4.4%

2009

1685

12.5%

1425

84.6%

200

11.9%

3.6%

2010

2041

15.1%

1728

84.7%

226

11.1%

4.3%

2011

2215

16.4%

1930

87.1%

209

9.4%

3.4%

2012

2322

17.2%

2020

87.0%

234

10.1%

2.9%

Zip Code Income Level

.003

($63K-+)

4840

35.9%

4180

86.4%

496

10.2%

164

3.4%

($48K-63K)

3908

29.0%

3349

85.7%

416

10.6%

143

3.7%

($38K-$48K)

2991

22.2%

2494

83.4%

380

12.7%

117

3.9%

(0-$38K)

1750

13.0%

1441

82.3%

239

13.7%

4.0%

		N	Prop (%)	N	Prop (%)	N	Prop (%)	N	Prop (%)	P χ²	Q1	Med	Q3	P KW
Time to Treatment Completion			40–46 days		47–53 days		54+ days			42	43	45
		13489		11464	85.0%	1531	11.3%	494	3.7%
Time to Treatment Initiation									< .001				< .001
	1-21 days	3044	22.6%	2471	81.2%	388	12.7%	185	6.1%		43	43	45
	22-42 days	8913	66.1%	7738	86.8%	924	10.4%	251	2.8%		42	43	44
	43+ days	1532	11.4%	1255	81.9%	219	14.3%	58	3.8%		43	43	45
Age										.439				.156
	(18-40)	731	5.4%	627	85.8%	76	10.4%	28	3.8%		42	43	45
	(40-50)	1671	12.4%	1422	85.1%	184	11.0%	65	3.9%		42	43	45
	(50-60)	3880	28.8%	3296	84.9%	440	11.3%	144	3.7%		42	43	45
	(60-70)	4471	33.1%	3830	85.7%	497	11.1%	144	3.2%		42	43	45
	(70-+)	2736	20.3%	2289	83.7%	334	12.2%	113	4.1%		43	43	45
Sex										.009				.012
	Male	8131	60.3%	6984	85.9%	876	10.8%	271	3.3%		42	43	45
	Female	5358	39.7%	4480	83.6%	655	12.2%	223	4.2%		43	43	45
Race										.001				.002
	White	X	92.1%	10596	85.3%	1383	11.1%	X	3.6%		42	43	45
	Black	X	4.9%	523	78.6%	105	15.8%	X	5.6%		43	43	45
	Asian	X	1.5%	187	89.5%	16	7.7%	X	2.9%		43	43	44
	Other	X	1.4%	158	81.9%	27	14.0%	X	4.1%		42	43	45
Hispanic Origin									.637				.068
	Non-Hispanic	12928	95.8%	10995	85.0%	1462	11.3%	471	3.6%		42	43	45
	Hispanic	561	4.2%	469	83.6%	69	12.3%	23	4.1%		43	43	45
Insurance Status									< .001				< .001
	Private Insurance	7580	56.2%	6540	86.3%	775	10.2%	265	3.5%		42	43	44
	Not Insured	477	3.5%	386	80.9%	73	15.3%	18	3.8%		43	44	45
	Government	5432	40.3%	4538	83.5%	683	12.6%	211	3.9%		43	43	45
Facility Type										.011				.004
	Academic	X	43.4%	X	85.4%	X	10.6%	X	3.9%		42	43	44
	Community	X	44.1%	X	84.5%	X	12.0%	X	3.5%		43	43	45
	Integrated	X	6.9%	X	84.8%	X	12.6%	X	2.6%		43	43	45
	Other	X	0.1%	X	60.0%	X	26.7%	X	13.3%		43	44	49
	Suppressed (age < 40)	X	5.4%	X	85.8%	X	10.4%	X	3.8%		42	43	45
Distance to Treatment Facility									.164				.002
	(0-50)	11811	87.6%	10035	85.0%	1344	11.4%	432	3.7%		42	43	45
	(50-100)	1063	7.9%	899	84.6%	131	12.3%	33	3.1%		43	43	45
	(100-+)	615	4.6%	530	86.2%	56	9.1%	29	4.7%		42	43	44
Charlson/Deyo Comorbidity Score									.303				.015
	0	10268	76.1%	8765	85.4%	1139	11.1%	364	3.5%		42	43	45
	1	2024	15.0%	1696	83.8%	247	12.2%	81	4.0%		43	43	45
	2+	1197	8.9%	1003	83.8%	145	12.1%	49	4.1%		43	43	45
Diagnosis Year									.003				< .001
	2005	1030	7.6%	856	83.1%	139	13.5%	35	3.4%		43	44	45
	2006	1230	9.1%	1023	83.2%	157	12.8%	50	4.1%		43	43	45
	2007	1405	10.4%	1178	83.8%	178	12.7%	49	3.5%		43	43	45
	2008	1561	11.6%	1304	83.5%	188	12.0%	69	4.4%		42	43	45
	2009	1685	12.5%	1425	84.6%	200	11.9%	60	3.6%		42	43	45
	2010	2041	15.1%	1728	84.7%	226	11.1%	87	4.3%		42	43	45
	2011	2215	16.4%	1930	87.1%	209	9.4%	76	3.4%		42	43	44
	2012	2322	17.2%	2020	87.0%	234	10.1%	68	2.9%		42	43	44
Zip Code Income Level									.003				.003
	($63K-+)	4840	35.9%	4180	86.4%	496	10.2%	164	3.4%		42	43	44
	($48K-63K)	3908	29.0%	3349	85.7%	416	10.6%	143	3.7%		42	43	45
	($38K-$48K)	2991	22.2%	2494	83.4%	380	12.7%	117	3.9%		42	43	45
	(0-$38K)	1750	13.0%	1441	82.3%	239	13.7%	70	4.0%		42	43	45

Prop (%)

P χ²

Med

P KW

Overall Cohort

TTI Groups

Time to Treatment Completion

40–46 days

47–53 days

54+ days

13489

11464

85.0%

1531

11.3%

494

3.7%

Time to Treatment Initiation

< .001

1-21 days

3044

22.6%

2471

81.2%

388

12.7%

185

6.1%

22-42 days

8913

66.1%

7738

86.8%

924

10.4%

251

2.8%

43+ days

1532

11.4%

1255

81.9%

219

14.3%

3.8%

Age

.439

.156

(18-40)

731

5.4%

627

85.8%

10.4%

3.8%

(40-50)

1671

12.4%

1422

85.1%

184

11.0%

3.9%

(50-60)

3880

28.8%

3296

84.9%

440

11.3%

144

3.7%

(60-70)

4471

33.1%

3830

85.7%

497

11.1%

144

3.2%

(70-+)

2736

20.3%

2289

83.7%

334

12.2%

113

4.1%

Sex

.009

.012

Male

8131

60.3%

6984

85.9%

876

10.8%

271

3.3%

Female

5358

39.7%

4480

83.6%

655

12.2%

223

4.2%

Race

.001

.002

White

92.1%

10596

85.3%

1383

11.1%

3.6%

Black

4.9%

523

78.6%

105

15.8%

5.6%

Asian

1.5%

187

89.5%

7.7%

2.9%

Other

1.4%

158

81.9%

14.0%

4.1%

Hispanic Origin

.637

.068

Non-Hispanic

12928

95.8%

10995

85.0%

1462

11.3%

471

3.6%

Hispanic

561

4.2%

469

83.6%

12.3%

4.1%

Insurance Status

< .001

Private Insurance

7580

56.2%

6540

86.3%

775

10.2%

265

3.5%

Not Insured

477

3.5%

386

80.9%

15.3%

3.8%

Government

5432

40.3%

4538

83.5%

683

12.6%

211

3.9%

Facility Type

.011

.004

Academic

43.4%

85.4%

10.6%

3.9%

Community

44.1%

84.5%

12.0%

3.5%

Integrated

6.9%

84.8%

12.6%

2.6%

Other

0.1%

60.0%

26.7%

13.3%

Suppressed (age < 40)

5.4%

85.8%

10.4%

3.8%

Distance to Treatment Facility

.164

.002

(0-50)

11811

87.6%

10035

85.0%

1344

11.4%

432

3.7%

(50-100)

1063

7.9%

899

84.6%

131

12.3%

3.1%

(100-+)

615

4.6%

530

86.2%

9.1%

4.7%

Charlson/Deyo Comorbidity Score

.303

.015

10268

76.1%

8765

85.4%

1139

11.1%

364

3.5%

2024

15.0%

1696

83.8%

247

12.2%

4.0%

1197

8.9%

1003

83.8%

145

12.1%

4.1%

Diagnosis Year

.003

< .001

2005

1030

7.6%

856

83.1%

139

13.5%

3.4%

2006

1230

9.1%

1023

83.2%

157

12.8%

4.1%

2007

1405

10.4%

1178

83.8%

178

12.7%

3.5%

2008

1561

11.6%

1304

83.5%

188

12.0%

4.4%

2009

1685

12.5%

1425

84.6%

200

11.9%

3.6%

2010

2041

15.1%

1728

84.7%

226

11.1%

4.3%

2011

2215

16.4%

1930

87.1%

209

9.4%

3.4%

2012

2322

17.2%

2020

87.0%

234

10.1%

2.9%

Zip Code Income Level

.003

($63K-+)

4840

35.9%

4180

86.4%

496

10.2%

164

3.4%

($48K-63K)

3908

29.0%

3349

85.7%

416

10.6%

143

3.7%

($38K-$48K)

2991

22.2%

2494

83.4%

380

12.7%

117

3.9%

(0-$38K)

1750

13.0%

1441

82.3%

239

13.7%

4.0%

Table 1

Open in new tab

Baseline Patient Demographics

		N	Prop (%)	N	Prop (%)	N	Prop (%)	N	Prop (%)	P χ²	Q1	Med	Q3	P KW
		Overall Cohort		TTI Groups
Time to Treatment Completion				40–46 days		47–53 days		54+ days			42	43	45
		13489		11464	85.0%	1531	11.3%	494	3.7%
Time to Treatment Initiation										< .001				< .001
	1-21 days	3044	22.6%	2471	81.2%	388	12.7%	185	6.1%		43	43	45
	22-42 days	8913	66.1%	7738	86.8%	924	10.4%	251	2.8%		42	43	44
	43+ days	1532	11.4%	1255	81.9%	219	14.3%	58	3.8%		43	43	45
Age										.439				.156
	(18-40)	731	5.4%	627	85.8%	76	10.4%	28	3.8%		42	43	45
	(40-50)	1671	12.4%	1422	85.1%	184	11.0%	65	3.9%		42	43	45
	(50-60)	3880	28.8%	3296	84.9%	440	11.3%	144	3.7%		42	43	45
	(60-70)	4471	33.1%	3830	85.7%	497	11.1%	144	3.2%		42	43	45
	(70-+)	2736	20.3%	2289	83.7%	334	12.2%	113	4.1%		43	43	45
Sex										.009				.012
	Male	8131	60.3%	6984	85.9%	876	10.8%	271	3.3%		42	43	45
	Female	5358	39.7%	4480	83.6%	655	12.2%	223	4.2%		43	43	45
Race										.001				.002
	White	X	92.1%	10596	85.3%	1383	11.1%	X	3.6%		42	43	45
	Black	X	4.9%	523	78.6%	105	15.8%	X	5.6%		43	43	45
	Asian	X	1.5%	187	89.5%	16	7.7%	X	2.9%		43	43	44
	Other	X	1.4%	158	81.9%	27	14.0%	X	4.1%		42	43	45
Hispanic Origin										.637				.068
	Non-Hispanic	12928	95.8%	10995	85.0%	1462	11.3%	471	3.6%		42	43	45
	Hispanic	561	4.2%	469	83.6%	69	12.3%	23	4.1%		43	43	45
Insurance Status										< .001				< .001
	Private Insurance	7580	56.2%	6540	86.3%	775	10.2%	265	3.5%		42	43	44
	Not Insured	477	3.5%	386	80.9%	73	15.3%	18	3.8%		43	44	45
	Government	5432	40.3%	4538	83.5%	683	12.6%	211	3.9%		43	43	45
Facility Type										.011				.004
	Academic	X	43.4%	X	85.4%	X	10.6%	X	3.9%		42	43	44
	Community	X	44.1%	X	84.5%	X	12.0%	X	3.5%		43	43	45
	Integrated	X	6.9%	X	84.8%	X	12.6%	X	2.6%		43	43	45
	Other	X	0.1%	X	60.0%	X	26.7%	X	13.3%		43	44	49
	Suppressed (age < 40)	X	5.4%	X	85.8%	X	10.4%	X	3.8%		42	43	45
Distance to Treatment Facility										.164				.002
	(0-50)	11811	87.6%	10035	85.0%	1344	11.4%	432	3.7%		42	43	45
	(50-100)	1063	7.9%	899	84.6%	131	12.3%	33	3.1%		43	43	45
	(100-+)	615	4.6%	530	86.2%	56	9.1%	29	4.7%		42	43	44
Charlson/Deyo Comorbidity Score										.303				.015
	0	10268	76.1%	8765	85.4%	1139	11.1%	364	3.5%		42	43	45
	1	2024	15.0%	1696	83.8%	247	12.2%	81	4.0%		43	43	45
	2+	1197	8.9%	1003	83.8%	145	12.1%	49	4.1%		43	43	45
Diagnosis Year										.003				< .001
	2005	1030	7.6%	856	83.1%	139	13.5%	35	3.4%		43	44	45
	2006	1230	9.1%	1023	83.2%	157	12.8%	50	4.1%		43	43	45
	2007	1405	10.4%	1178	83.8%	178	12.7%	49	3.5%		43	43	45
	2008	1561	11.6%	1304	83.5%	188	12.0%	69	4.4%		42	43	45
	2009	1685	12.5%	1425	84.6%	200	11.9%	60	3.6%		42	43	45
	2010	2041	15.1%	1728	84.7%	226	11.1%	87	4.3%		42	43	45
	2011	2215	16.4%	1930	87.1%	209	9.4%	76	3.4%		42	43	44
	2012	2322	17.2%	2020	87.0%	234	10.1%	68	2.9%		42	43	44
Zip Code Income Level										.003				.003
	($63K-+)	4840	35.9%	4180	86.4%	496	10.2%	164	3.4%		42	43	44
	($48K-63K)	3908	29.0%	3349	85.7%	416	10.6%	143	3.7%		42	43	45
	($38K-$48K)	2991	22.2%	2494	83.4%	380	12.7%	117	3.9%		42	43	45
	(0-$38K)	1750	13.0%	1441	82.3%	239	13.7%	70	4.0%		42	43	45

		N	Prop (%)	N	Prop (%)	N	Prop (%)	N	Prop (%)	P χ²	Q1	Med	Q3	P KW
		Overall Cohort		TTI Groups
Time to Treatment Completion				40–46 days		47–53 days		54+ days			42	43	45
		13489		11464	85.0%	1531	11.3%	494	3.7%
Time to Treatment Initiation										< .001				< .001
	1-21 days	3044	22.6%	2471	81.2%	388	12.7%	185	6.1%		43	43	45
	22-42 days	8913	66.1%	7738	86.8%	924	10.4%	251	2.8%		42	43	44
	43+ days	1532	11.4%	1255	81.9%	219	14.3%	58	3.8%		43	43	45
Age										.439				.156
	(18-40)	731	5.4%	627	85.8%	76	10.4%	28	3.8%		42	43	45
	(40-50)	1671	12.4%	1422	85.1%	184	11.0%	65	3.9%		42	43	45
	(50-60)	3880	28.8%	3296	84.9%	440	11.3%	144	3.7%		42	43	45
	(60-70)	4471	33.1%	3830	85.7%	497	11.1%	144	3.2%		42	43	45
	(70-+)	2736	20.3%	2289	83.7%	334	12.2%	113	4.1%		43	43	45
Sex										.009				.012
	Male	8131	60.3%	6984	85.9%	876	10.8%	271	3.3%		42	43	45
	Female	5358	39.7%	4480	83.6%	655	12.2%	223	4.2%		43	43	45
Race										.001				.002
	White	X	92.1%	10596	85.3%	1383	11.1%	X	3.6%		42	43	45
	Black	X	4.9%	523	78.6%	105	15.8%	X	5.6%		43	43	45
	Asian	X	1.5%	187	89.5%	16	7.7%	X	2.9%		43	43	44
	Other	X	1.4%	158	81.9%	27	14.0%	X	4.1%		42	43	45
Hispanic Origin										.637				.068
	Non-Hispanic	12928	95.8%	10995	85.0%	1462	11.3%	471	3.6%		42	43	45
	Hispanic	561	4.2%	469	83.6%	69	12.3%	23	4.1%		43	43	45
Insurance Status										< .001				< .001
	Private Insurance	7580	56.2%	6540	86.3%	775	10.2%	265	3.5%		42	43	44
	Not Insured	477	3.5%	386	80.9%	73	15.3%	18	3.8%		43	44	45
	Government	5432	40.3%	4538	83.5%	683	12.6%	211	3.9%		43	43	45
Facility Type										.011				.004
	Academic	X	43.4%	X	85.4%	X	10.6%	X	3.9%		42	43	44
	Community	X	44.1%	X	84.5%	X	12.0%	X	3.5%		43	43	45
	Integrated	X	6.9%	X	84.8%	X	12.6%	X	2.6%		43	43	45
	Other	X	0.1%	X	60.0%	X	26.7%	X	13.3%		43	44	49
	Suppressed (age < 40)	X	5.4%	X	85.8%	X	10.4%	X	3.8%		42	43	45
Distance to Treatment Facility										.164				.002
	(0-50)	11811	87.6%	10035	85.0%	1344	11.4%	432	3.7%		42	43	45
	(50-100)	1063	7.9%	899	84.6%	131	12.3%	33	3.1%		43	43	45
	(100-+)	615	4.6%	530	86.2%	56	9.1%	29	4.7%		42	43	44
Charlson/Deyo Comorbidity Score										.303				.015
	0	10268	76.1%	8765	85.4%	1139	11.1%	364	3.5%		42	43	45
	1	2024	15.0%	1696	83.8%	247	12.2%	81	4.0%		43	43	45
	2+	1197	8.9%	1003	83.8%	145	12.1%	49	4.1%		43	43	45
Diagnosis Year										.003				< .001
	2005	1030	7.6%	856	83.1%	139	13.5%	35	3.4%		43	44	45
	2006	1230	9.1%	1023	83.2%	157	12.8%	50	4.1%		43	43	45
	2007	1405	10.4%	1178	83.8%	178	12.7%	49	3.5%		43	43	45
	2008	1561	11.6%	1304	83.5%	188	12.0%	69	4.4%		42	43	45
	2009	1685	12.5%	1425	84.6%	200	11.9%	60	3.6%		42	43	45
	2010	2041	15.1%	1728	84.7%	226	11.1%	87	4.3%		42	43	45
	2011	2215	16.4%	1930	87.1%	209	9.4%	76	3.4%		42	43	44
	2012	2322	17.2%	2020	87.0%	234	10.1%	68	2.9%		42	43	44
Zip Code Income Level										.003				.003
	($63K-+)	4840	35.9%	4180	86.4%	496	10.2%	164	3.4%		42	43	44
	($48K-63K)	3908	29.0%	3349	85.7%	416	10.6%	143	3.7%		42	43	45
	($38K-$48K)	2991	22.2%	2494	83.4%	380	12.7%	117	3.9%		42	43	45
	(0-$38K)	1750	13.0%	1441	82.3%	239	13.7%	70	4.0%		42	43	45

Abbreviations: KW, Kruskal-Wallis; Med, median; Q1, first quartile; Q3, third quartile; TTI, time to initiation.

Values denoted with “X” represent single-digit values redacted per the National Cancer Database data use agreement.

This Feature Is Available To Subscribers Only